Ultradeformable liposomal delivery of vismodegib modulates its biological activity in melanoma cells
{{output}}
Introduction: Vismodegib (VDG), a Smoothened inhibitor approved for basal cell carcinoma, has potential for repurposing in other tumors in which Hedgehog (Hh) signaling contributes to malignancy. However, systemic VDG treatment i... ...
